✦ LIBER ✦

The safety and efficacy of adding once-daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countries

✍ Scribed by K. Khunti; S. Caputo; T. Damci; G. J. Dzida; Q. Ji; M. Kaiser; E. Karnieli; A. Liebl; R. J. Ligthelm; A. Nazeri; D. Orozco-Beltran; C. Pan; S. A. Ross; A. L. Svendsen; J. Vora; J.-F. Yale; L. F. Meneghini; on behalf of the SOLVE Study Group

Book ID: 117949639
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 604 KB
Volume: 14
Category: Article
ISSN: 1462-8902
DOI: 10.1111/j.1463-1326.2012.01665.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Once-Weekly Exenatide Versus Once- or Tw

Once-Weekly Exenatide Versus Once- or Twice-Daily Insulin Detemir: Randomized, open-label, clinical trial of efficacy and safety in patients with type 2 diabetes treated with metformin alone or in combination with sulfonylureas

✍ Davies, M.; Heller, S.; Sreenan, S.; Sapin, H.; Adetunji, O.; Tahbaz, A.; Vora, 📂 Article 📅 2012 🏛 American Diabetes Association 🌐 English ⚖ 223 KB

Safety and efficacy of adding sitaglipti

Safety and efficacy of adding sitagliptin to insulin in patients with type 2 diabetes: The ASSIST-K study

✍ Takai, Masahiko; Ishikawa, Masashi; Maeda, Hajime; Kanamori, Akira; Kubota, Akir 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 420 KB

Safety and efficacy of insulin detemir i

Safety and efficacy of insulin detemir in clinical practice: 14-week follow-up data from type 1 and type 2 diabetes patients in the PREDICTIVETM European cohort

✍ A. Dornhorst; H-J Lüddeke; S. Sreenan; C. Koenen; J. B. Hansen; A. Tsur; L. Land 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 516 KB

Less weight gain and hypoglycaemia with

Less weight gain and hypoglycaemia with once-daily insulin detemir than NPH insulin in intensification of insulin therapy in overweight Type 2 diabetes patients—The PREDICTIVE™ BMI clinical trial

✍ C. Fajardo Montañana; C. Hernández Herrero; M. Rivas Fernández 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 264 KB

Effects of the combination of insulin an

Effects of the combination of insulin and glibenclamide in Type 2 (non-insulin-dependent) diabetic patients with secondary failure to oral hypoglycaemic agents

✍ S. Stenman; P. -H. Groop; C. Saloranta; K. J. Tötterman; F. Fyhrqvist; L. Groop 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 971 KB

The effects of combined insulin and sulfonylurea therapy on glycaemic control and B-cell function was studied in 15 Type 2 (non-insulin-dependent) diabetic patients who had failed on treatment with oral hypoglycaemic agents. The patients were first treated with insulin alone for four months. Five pa

Therapy conversion to insulin detemir am

Therapy conversion to insulin detemir among patients with type 2 diabetes treated with oral agents: A modeling study of cost-effectiveness in the United States

✍ William J. Valentine; K. M. Erny-Albrecht; J. A. Ray; S. Roze; D. Cobden; A. J. 📂 Article 📅 2007 🏛 Springer Healthcare Communications 🌐 English ⚖ 225 KB